GM-CSF: intravenous versus subcutaneous treatment.

Aglietta, M; Monzeglio, C; Piacibello, W; Aprá, F; Stacchini, A; Sanavio, F; Mossetti, C; Stern, A C; Gavosto, F

Aglietta, M; Monzeglio, C; Piacibello, W; Aprá, F; Stacchini, A; Sanavio, F; Mossetti, C; Stern, A C; Gavosto, F.

Affiliation

Aglietta M; Clinica Medica A, Universitá di Torino, Italy.

Leukemia ; 4(7): 523, 1990 Jul.

Article in En | MEDLINE | ID: mdl-2197516

Subject(s)

Colony-Stimulating Factors/administration & dosage; Growth Substances/administration & dosage; Colony-Stimulating Factors/therapeutic use; Drug Evaluation; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances/therapeutic use; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leukocytes/drug effects; Neoplasms/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colony-Stimulating Factors / Growth Substances Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1990 Document type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links